TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial.

Jun-Jie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.